A2DMQY Cronos Group Inc

Cronos Group Inc. to Hold Virtual 2020 Annual and Special Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2020 Annual and Special Meeting of Shareholders

TORONTO, May 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Annual and Special Meeting of Shareholders on Thursday, June 25, 2020, at 10:00 a.m. EDT.

Due to the continued public health concerns related to the COVID-19 pandemic, to mitigate risks to the health and safety of our communities, shareholders, employees and other stakeholders, Cronos Group will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2020 Annual and Special Meeting online regardless of their geographic location, including a chance to ask questions and vote.

The Company’s proxy statement describing the formal business to be conducted at the meeting and containing detailed instructions about how to participate in the meeting is available on the Investors section of the Company’s website at .

Access Information

Date: Thursday, June 25, 2020

Time: 10:00 a.m. EDT

Live Audio Webcast Online at:

Password: cronos2020

Replay

A replay of the Annual and Special Meeting will be available in the investor relations section of the Company’s website () starting about 24 hours after the meeting is finished.

About Cronos Group Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio. Cronos Group’s portfolio includes ™, a global wellness platform, two adult-use brands, ™ and ™, and two hemp-derived CBD brands, ™ and ™. For more information about Cronos Group and its brands, please visit: 

Forward-looking Statements

This press release may contain information that may constitute “forward‐looking information” or “forward‐looking statements” within the meaning of applicable Canadian and U.S. securities laws (collectively, “Forward-looking Statements”).  All information contained herein that is not clearly historical in nature may constitute Forward‐looking Statements.  In some cases, Forward‐looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward‐looking Statements.  Forward‐looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward‐looking Statements and the Forward‐looking Statements are not guarantees of future performance.  A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (as amended) and the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2020, both of which have been filed on SEDAR and EDGAR and can be accessed at and , respectively.  Any Forward‐looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any Forward‐ looking Statement.  Readers are cautioned not to put undue reliance on any Forward‐looking Statement.

Cronos Group Contact

Anna Shlimak

Tel: (416) 504-0004

EN
15/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Group Reports 2025 Second Quarter Results

Cronos Group Reports 2025 Second Quarter Results Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 second quarter business results. "Cronos delivered another quarter of str...

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call...

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025 TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 second quarter earnings conference call on Thursday, August 7, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage partic...

 PRESS RELEASE

Cronos Grows its International Footprint in Switzerland

Cronos Grows its International Footprint in Switzerland TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training. “We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, ...

 PRESS RELEASE

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Sharehol...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was...

 PRESS RELEASE

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Co...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch